However, the mutation screeening of POU4F2 showed no apparent pathogenic alterations in the coding and regulatory parts of the gene, nor did we find any methylated CpG sites in the primary tumours, suggesting that the lower gene expression seen in UF tumours are not due to genetic alterations or DNA methylation. The gene discussed is POU4F2; the disease is neoplasm.